Abstract:We previously have found that 2-chloroethyl-3-sarcosinamide1-nitrosourea (SarCNU) is a selective cytotoxin that enters cells via the extraneuronal transporter for monoamine transmitters (EMT). Both in vitro and in vivo studies demonstrated that SarCNU was more effective than BCNU against human gliomas. To clarify whether EMT expression correlates with antitumor efficacy of SarCNU, we determined human EMT (EMTh) and O-6-methylguanine-DNA methyltransferase (MGMT) expression in nine human xenograft models using semiquantitative reverse-transcription polymerase chain reaction. These results were compared with the antitumor effects of SarCNU and the standard chloroethylnitrosourea antitumor agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). There was no significant correlation between EMTh expression and antitumor efficacy of SarCNU or BCNU. Also, there was no significant correlation between MGMT expression and SarCNU efficacy. However, a significant correlation was found between MGMT expression and BCNU antitumor efficacy. Interestingly, multiple regression analysis demonstrated a significant correlation between SarCNU efficacy and EMTh plus MGMT expression, whereas there was no correlation between BCNU efficacy and MGMT plus EMTh expression. Thus, the absence of a linear correlation between SarCNU efficacy and EMTh expression appears to be due, at least in part, to the presence of DNA repair, specifically, MGMT, in these xenograft models. These studies suggest that MGMT expression alone correlates with BCNU activity, whereas both EMTh and MGMT expression are important determinants of SarCNU activity against human tumor xenograft models. SarCNU is in clinical trials and these results may have important clinical implications.

[Anti-Tumor Efficacy of 2-Chloroethyl-3-sarcosinamide-1-nitrosourea in a Human Lung Cancer Xenograft Model with DNA Repair Gene Expressions].

Both extraneuronal monoamine transporter and O6-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide-1-nitrosourea in human tumor xenografts

Antitumor effect of sarcnu in a 0 6 -methylguanine-DNA methyltransferase positive human glioma xenograft model

Antitumor Effect of Sarcnu in a 06-Methylguanine-dna Methyltransferase Positive Human Glioma Xenograft Model

Enhanced Antitumor Activity of SarCNU in Comparison to BCNU in an Extraneuronal Monoamine Transporter Positive Human Glioma Xenograft Model

Antitumor Efficacy of SarCNU in a Human Glioma Xenograft Model Expressing Both MGMT and Extraneuronal Monoamine Transporter

Expression of extraneuronal monoamine transporter gene and DNA repair gene vis -à-vis with antitumor efficacy of SarCNU in human tumor xenografts

Therapeutic effect of SarCNU in the treatment of human glioma nude mice model

Extraneuronal Monoamine Transporter Expression in Human Tumor Cell Lines

The Superparamagnetic Nanoparticles Carrying the E1A Gene Enhance the Radiosensitivity of Human Cervical Carcinoma in Nude Mice

Relationship Between ERCC1 Expression and Efficacy of Neoadjuvant Chemotherapy in the Patients with Non-Small-cell Lung Cancer

The Anticancer Effects of Sodium Selenite and Selenomethionine on Human Colorectal Carcinoma Cell Lines in Nude Mice

Antitumor effect of nitidine chloride in vitro and in vivo

Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.

Experimental Study on Anti-angiogenesis in Mice with Sarcoma S-180 by Ginsenoside Rg3 Combined with Low-dose of Cyclophosphamide

Glycol Chitosan Incorporated Retinoic Acid Chlorochalcone (RACC) Nanoparticles in the Treatment of Osteosarcoma

Preliminary Studies on the Antitumor Activities of D-glucosamine and Its Derivatives

Using a Hybrid Radioenhancer to Discover Tumor Cell-targeted Treatment for Osteosarcoma: An In Vitro Study

Effect of EGFR Antagonists Gefitinib (iressa) and C225 (cetuximab) on MnSOD-plasmid Liposome Transgene Radiosensitization of a Murine Squamous Cell Carcinoma Cell Line.

Effect of 2-[(3-carboxy-1-oxoprogyl) Amino]-2-deoxy-d-glucose on Esophageal Cancer in Nude Mice and Expression of Its Relational Genes